FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/077357 [Registered on: 26/11/2024] Trial Registered Prospectively
Last Modified On: 03/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A randomised study of Comparison of ease of insertion and nasal bleeding with Ivory Polyvinylchloride north pole tube versus reinforced Armored tube in patients undergoing head and neck surgery under general anesthesia with video-laryngoscope guided insertion of tube through nose in airway pipe. 
Scientific Title of Study   Comparison of ease of intubation and epistaxis with Ivory Polyvinylchloride north pole versus Armored tube in patients undergoing head and neck surgery under general anesthesia with video-laryngoscope guided nasotracheal intubation: A randomized parallel arm study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shreya Pawar 
Designation  Junior Resident (Anesthesia) 
Affiliation  AIIMS BHOPAL 
Address  Department of Anesthesiology,AIIMS bhopal,Saket Nagar

Bhopal
MADHYA PRADESH
462026
India 
Phone  7999635918  
Fax    
Email  shreyapawar1309@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sunaina Tejpal Karna 
Designation  Additional Professor 
Affiliation  AIIMS BHOPAL 
Address  Department of Anesthesiology,AIIMS Bhopal,Saket Nagar, Bhopal.

Bhopal
MADHYA PRADESH
462020
India 
Phone  9540946869  
Fax    
Email  drtejpal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sunaina Tejpal Karna 
Designation  Additional Professor 
Affiliation  AIIMS BHOPAL 
Address  Department of Anesthesiology,Third floor, Trauma Block, Hospital building, AIIMS Bhopal,Saket Nagar

Bhopal
MADHYA PRADESH
462020
India 
Phone  9540946869  
Fax    
Email  drtejpal@gmail.com  
 
Source of Monetary or Material Support  
NA 
 
Primary Sponsor  
Name  All India Institute of Medical Sciences Bhopal 
Address  Department of Anesthesiology, AIIMS Bhopal, Saket Nagar, Bhopal, Madhya Pradesh- 462020  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sunaina Tejpal Karna  All India Institute of Medical Sciences Bhopal  Department of Anesthesiology, Third floor, Hospital building, Saket Nagar, Bhopal. 462020
Bhopal
MADHYA PRADESH 
09540946869

drtejpal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Human Ethics Committee- Student Research (IHEC-SR)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C01||Malignant neoplasm of base of tongue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Armored endotracheal tube  Armored endotracheal tube will be inserted after induction of general anesthesia using video laryngoscopy guided nasotracheal intubation in patients undergoing head and neck surgery. The tube will remain in situ for the duration of surgery. 
Intervention  Ivory polyvinylchloride north pole tube  Ivory PVC North pole tube will be inserted after induction of general anesthesia using video laryngoscopy guided nasotracheal intubation in patients undergoing head and neck surgery. The tube will remain in situ for the duration of surgery. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  ASA I and II undergoing elective head and neck surgeries with nasotracheal intubation under general anaesthesia 
 
ExclusionCriteria 
Details  1.Anticipated difficult laryngoscopy with Mallampati Classification III or IV, mouth opening less than 3 cm, Thyromental distance less than 6cm, limited neck extension, history of history of documented difficult tracheal intubation.
2.Poor cardiorespiratory reserve- Serious respiratory disease, Arrythmias or preexisting hemodynamic instability, LVEF less than 35%.
3.Contraindication to nasotracheal intubation -Bilateral nasal polyp, Adenoids, chronic suppurative Sinusitis, cervical spine instability, coagulopathy Low platelet count less than 1 lakhs/cumm, INR more than 1.4, on ongoing anticoagulant therapy.
4. Vulnerable patients- Pregnancy, psychiatric illness, pediatric age group.
5.We will also exclude patients where the experienced anesthesiologist is unable to insert endotracheal tube nasally or insert video-laryngoscope in oral cavity due to unanticipated causes or is unable to obtain any glottic view. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1)Frequency of epistaxis in nasotracheal intubation with ivory polyvinyl chloride North
Polar tube versus armored endotracheal tube with Video laryngoscope guided
nasotracheal intubation in patients undergoing head and neck surgery.
2)Frequency of patients with easy, minor difficult and difficult intubation difficult score in
nasotracheal intubation with Ivory polyvinyl chloride North Polar tube versus armored
endotracheal tube with Video laryngoscope guided nasotracheal intubation in patients
undergoing head and neck surgery 
1) 5 minutes after intubation.
2) During Induction 
 
Secondary Outcome  
Outcome  TimePoints 
1 Time needed in seconds (total and phase wise)for nasotracheal intubation in Ivory
polyvinyl chloride North Polar tube versus armored endotracheal tube with Video laryngoscope guided nasotracheal intubation in patients undergoing head and neck
surgery.  
During induction 
To compare hemodynamic response and complications in Ivory polyvinyl chloride
North Polar tube versus armored endotracheal tube with Video-laryngoscope guided
nasotracheal intubation in patients undergoing head and neck surgery. 
At start of preoxygenation,laryngoscopy,and 1,3,5 and 10 minutes after intubation.  
To compare complications of tube related complications (cuff tear, blockage), injury(dental, nasal, vocal cord) and delayed complications (postoperative sore throat, hoarseness, dysphagia.  Post operative at 48 hours after surgery. 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   On the day prior to Surgery, patients who meet the inclusion and exclusion criteria will be identified, provided with a patient information sheet, and have the study protocol explained to them. Informed consent will be obtained after the procedure details are explained. Key preoperative measurements ,including age, gender, body mass index, inter incisor distance, thyromental distance, Mallampati classification, and upper lip bite test, will be recorded, along with the American Society of Anesthesiologist physical grade and planned surgery type . An Otolaryngologist will perform nasal endoscopy to identify a patent nostril, with the right nostril chosen for nasotracheal intubtion if no significant difference is observed. Participants will be randomized into two groups group N and Group A on the day of surgery using a computer-generated random number and allocated via sealed envelopes to ensure concealment. Blinding will be maintained for the patient and data analyst, though blinding the intubating anesthetics will not be possible due to the nature of the study. 
The study focuses on assessing the primary outcome of epistaxis in patients using two different types of tubes: the Portex North Polar Tube (NPT) and a PVC cuffed armored endotracheal tube. Based on previous research by Özkan ASM et al. (2018), which reported an epistaxis incidence of 2.9% for NPT and 22.9% for the armored tube, a sample size calculation determined that 96 patients would be needed (48 per group) to achieve an 80% power at a significance level of 0.05. Factoring in a 10% dropout rate, the study will recruit a total of 100 patients. The earlier study also highlighted that significantly more patients required laryngeal compression (42.9% vs. 11.4%) and changes in head position (45.7% vs. 2.9%) when using the armored tube.

For the study, the intervention devices include the Ivory PVC cuffed nasotracheal tube for Group N and the PVC cuffed armored endotracheal tube for Group A, with intubation performed using a C-MAC video laryngoscope with a D blade. The standardized anesthesia protocol involves pre-operative preparation that includes ensuring fasting guidelines and nasal preparation with 0.1% Xylometazoline. Once in the operating room, wide-bore IV access and standard monitoring (ECG, NIBP, pulse oximetry) will be established. Patients will receive premedication with IV Midazolam, followed by preoxygenation and induction with Fentanyl and Propofol. Rocuronium will be administered as a muscle relaxant before an experienced anesthetist performs the nasotracheal intubation.

During intubation, the lubricated tube will be inserted through the selected nostril, with the video laryngoscope used for guidance. The anesthetist will document any aids used, the time taken for intubation, and any complications encountered. After intubation, hemodynamic parameters will be monitored, and any incidents of nasal or oral bleeding will be recorded. An independent anesthetist will evaluate the intubation difficulty and the incidence of epistaxis five minutes post-intubation. Follow-up assessments will occur 48 hours post-surgery to check for sore throat, hoarseness, and dysphagia. This structured approach aims to rigorously evaluate the safety and efficacy of the two intubation techniques.
 
Close